PVR and hepatocellular carcinoma: Overexpression of PVR has been reported in many cancers including melanoma (14), lung adenocarcinoma (15), ovarian cancer (16), myeloid leukemia (17), neuroblastoma (18), pancreatic cancer (19), colorectal cancer (20), hepatocellular carcinoma (21), and bladder cancer (22).